@dpavot:17982252 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/@dpavot/sourceid/17982252","sourcedb":"@dpavot","sourceid":"17982252","source_url":"https://www.ncbi.nlm.nih.gov/pubmed/17982252","text":"The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (SLC1A6, SLC1A2 GRIN1, GRIN2A, GRIA1, NRG1, ErbB4, DTNBP1, DAAO, G72/30, GRM3).","tracks":[{"project":"PGR-UNK","denotations":[{"id":"T1","span":{"begin":246,"end":251},"obj":"2066"},{"id":"T2","span":{"begin":32,"end":45},"obj":"HP:0100753"}],"relations":[{"id":"R1","pred":"unknown","subj":"T2","obj":"T1"}],"attributes":[{"subj":"T1","pred":"source","obj":"PGR-UNK"},{"subj":"T2","pred":"source","obj":"PGR-UNK"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"PGR-UNK","color":"#ecc993","default":true}]}]}}